CONFIDENTIAL TREATMENT REQUESTED – REDACTED COPY LICENSE, DEVELOPMENT, MANUFACTURING & MARKETING AGREEMENTLicense, Development, Manufacturing & Marketing Agreement • September 13th, 2021 • Context Therapeutics Inc. • Pharmaceutical preparations • New York
Contract Type FiledSeptember 13th, 2021 Company Industry JurisdictionThis LICENSE, DEVELOPMENT, MANUFACTURING & MARKETING AGREEMENT (this “Agreement”) is entered into as of August 23, 2021 (the “Effective Date”) by and between Context Therapeutics LLC, a Delaware limited liability company having its registered offices at 3675 Market Street, Suite 200, Philadelphia, PA 19104 (“Context”), and Tyligand Bioscience (Shanghai) Limited a corporation organized under the laws of China and having offices at 3728 Jinke Lu, Building 1, West Wing, ZhangJiang Hitech Park, Shanghai, China (“Tyligand”). Each of Context and Tyligand is sometimes referred to individually herein as a “Party” and collectively the “Parties”.